This week, we welcome back Deepak Anand (CEO) and Nick Pateras (Managing Director, Europe) of Materia – Cannabis and CBD supply and distribution company serving the growing cannabis and CBD markets in Europe.
In this episode, we investigate the different types of medical cannabis, the importance of Good Manufacturing Process (GMP), and the globalisation of the medical cannabis supply chain.
→ View full show notes, summary, and access resources here:
Mr. Anand has a wealth of knowledge and experience in the global cannabis industry. He is a public speaker and is regularly engaged with Canadian and International media on all subjects related to the Cannabis industry. Mr. Anand holds a Master’s in Business Administration (MBA) and Management from Vancouver Island University. He is a recognized thought leader and brings15 years of leadership experience in the health, charitable/non-profit, and private sectors in Canada. Within the global cannabis sector, Mr. Anand has worked with senior government officials, politicians, policy makers, health professional organizations, clinical practitioners, educators, investors, patients as well as producers. He has also serves on the boards of various for and not for profit businesses and entities in the Cannabis sector. Currently, Mr. Anand serves as the Chief Executive Officer for Materia Ventures . Materia is a manufacturer and distributor of medical cannabis and CBD products across the burgeoning European market with offices and facilities in the UK, Germany, Malta as well as Canada.
Nick Pateras is Managing Director, Europe at Materia, where he oversees the company’s operations across Germany, Malta and the UK. Materia is a manufacturer and distributor of medical cannabis and CBD products across the burgeoning European market. Previously, Nick served as Vice President, Strategy at Lift & Co., Canada’s leading cannabis education and insights platform. He is a regular speaker at cannabis conferences across North America and Europe and taught the Cannabis Business Fundamentals course at George Brown College in Toronto in 2018-19. Prior to his time in cannabis, Nick spent several years in the pharmaceutical sector with Johnson & Johnson Inc, managing various category-leading OTC and Health & Beauty businesses.
‘There’s always stigma associated with cannabis, anyone who thinks otherwise would probably be naive’ 01:58
‘What’s really exciting to us is seeing the establishment fna implementation of global supply chains’. 32:53
‘Legacy patients are comfortable with flower, they’re not looking to switch. But if you can get extracts to a place where they are covered by insurers, that would be an appealing proposition’ 36:40